SG Americas Securities
KURA icon

SG Americas Securities’s Kura Oncology KURA Stock Holding History

SG Americas Securities’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Buy
63,396
+13,580
+27% +$128K ﹤0.01% 2128
2026
Q1 		$405K Sell
49,816
-101,899
-67% -$875K ﹤0.01% 2301
2025
Q4 		$1.58M Buy
151,715
+103,411
+214% +$1.09M ﹤0.01% 1680
2025
Q3 		$427K Buy
+48,304
New +$344K ﹤0.01% 2229
2025
Q2 		– Sell
-42,121
Closed -$278K – 3285
2025
Q1 		$278K Sell
42,121
-7,918
-16% -$61.7K ﹤0.01% 2271
2024
Q4 		$436K Buy
+50,039
New +$720K ﹤0.01% 1462
2024
Q2 		– Sell
-5,174
Closed -$110K – 3085
2024
Q1 		$110K Buy
+5,174
New +$101K ﹤0.01% 2482
2023
Q3 		– Sell
-36,983
Closed -$391K – 3186
2023
Q2 		$391K Buy
36,983
+9,858
+36% +$117K ﹤0.01% 1515
2023
Q1 		$332K Buy
27,125
+18,383
+210% +$229K ﹤0.01% 2048
2022
Q4 		$108K Buy
8,742
+35
+0.4% +$509 ﹤0.01% 2664
2022
Q3 		$119K Sell
8,707
-46,212
-84% -$713K ﹤0.01% 2727
2022
Q2 		$1.01M Sell
54,919
-42,562
-44% -$612K 0.01% 1295
2022
Q1 		$1.57M Sell
97,481
-77,370
-44% -$1.12M 0.01% 1088
2021
Q4 		$2.45M Buy
174,851
+56,550
+48% +$916K 0.01% 933
2021
Q3 		$2.22M Buy
118,301
+18,651
+19% +$351K 0.01% 1176
2021
Q2 		$2.08M Buy
99,650
+838
+0.8% +$20.8K 0.01% 1097
2021
Q1 		$2.79M Buy
98,812
+9,751
+11% +$309K 0.01% 835
2020
Q4 		$2.91M Sell
89,061
-12,763
-13% -$448K 0.02% 835
2020
Q3 		$3.12M Buy
101,824
+47,012
+86% +$1.04M 0.02% 518
2020
Q2 		$893K Buy
54,812
+39,693
+263% +$573K 0.01% 1529
2020
Q1 		$150K Buy
15,119
+7,107
+89% +$81.4K ﹤0.01% 2708
2019
Q4 		$110K Sell
8,012
-95,826
-92% -$1.42M ﹤0.01% 2900
2019
Q3 		$1.57M Buy
103,838
+96,885
+1,393% +$1.72M 0.01% 1120
2019
Q2 		$137K Buy
+6,953
New +$115K ﹤0.01% 2629

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

SG Americas Securities's KURA Position: Q2 2026 in Review

SG Americas Securities increased its Kura Oncology (KURA) stake by 27% in Q2 2026, buying an estimated $128K and bringing the position to 63,396 shares worth $695K. The position accounts for ﹤0.01% of the portfolio, ranked #2128.

SG Americas Securities first reported a position in KURA in Q2 2019 and has held it in 24 quarters since. The position peaked at $3.12M in Q3 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • SG Americas Securities held 63,396 shares of Kura Oncology worth $695K as of Q2 2026.
  • SG Americas Securities bought 13,580 Kura Oncology shares in Q2 2026, an estimated $128K.
  • Kura Oncology made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2128 holding.
  • SG Americas Securities first reported a position in Kura Oncology in Q2 2019 and has held it in 24 quarters since.
  • SG Americas Securities's Kura Oncology position peaked at $3.12M in Q3 2020.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.